Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-04Clinical Trial Update: Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2) [Phase 4]
Phase 4 trial update on dapagliflozin examining cholesterol metabolism in type 2 diabetes and hypercholesterolemia; study completed with res…
-
CLINICAL_TRIALS trial_result · 2020-08-04Clinical Trial Update: A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity [Phase 2]
A Phase 2 study comparing injection site pain for two semaglutide formulations using two different injection pens in healthy volunteers and …
-
FDA label_change · 2020-07-29FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) to update the labeling and potentially expand its approved u…
-
FDA approval · 2020-07-29FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) from Cosette Pharmaceuticals, Inc., indicating an approv…
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Artificial Intelligence Assisted Insulin Titration System [Phase 4]
Clinical trial update for an AI-assisted insulin titration system in type 2 diabetes completed Phase 4.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-07-24Clinical Trial Update: Bosentan Use in Patients With Diabetic Nephropathy [Phase 3]
A Phase 3 clinical trial investigating bosentan in patients with diabetic nephropathy has been terminated.
-
CLINICAL_TRIALS trial_result · 2020-07-24Clinical Trial Update: Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression [Phase 4]
A Phase 4 trial comparing metformin to vildagliptin to reduce progression of complications in metabolic syndrome and type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2020-07-24Clinical Trial Update: Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study [Phase 2]
Phase 2 trial investigating empagliflozin with ACE inhibitors for hyperfiltration in diabetes patients completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-07-21Clinical Trial Update: A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin [Phase 2]
Phase 2 study evaluating once-daily NNC0090-2746 in adults with type 2 diabetes inadequately controlled on metformin (completed).
-
CLINICAL_TRIALS trial_result · 2020-07-21Clinical Trial Update: Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients [Phase 4]
Phase 4 clinical trial update exploring the relationship between improvements in insulin secretion and reductions in HbA1c in GLP-1 receptor…
-
CLINICAL_TRIALS trial_result · 2020-07-20Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes [Phase 2]
A phase 2 trial evaluating MEDI0382 for efficacy and safety in overweight/obese individuals with type 2 diabetes has completed, with results…
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: MedStar Health Type 2 Diabetes Pathway to Control [NA]
A completed clinical trial for a Type 2 Diabetes pathway to control with posted results.
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: Janagliflozin Treat T2DM Monotherapy [Phase 3]
A Phase 3 clinical trial update for janagliflozin as monotherapy in type 2 diabetes is in development, with the status currently unknown.
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin [Phase 3]
Clinical trial update for janagliflozin in adults with type 2 diabetes inadequately controlled with metformin (Phase 3).
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Empagliflozin and Sympathetic Nerve Traffic [Phase 4]
Phase 4 clinical trial investigating empagliflozin and sympathetic nerve traffic in type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-10Clinical Trial Update: Effects of Insulin Glargine and Lixisenatide on the Brain [Phase 4]
A Phase 4 trial evaluating the effects of insulin glargine and lixisenatide on the brain in individuals with type 2 diabetes was terminated.
-
CLINICAL_TRIALS trial_result · 2020-07-08Clinical Trial Update: Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of liraglutide for type 2 diabetes is in an unknown status.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes [Phase 4]
Phase 4 trial evaluating liraglutide (Victoza) added to metformin versus other oral antidiabetic drugs added to metformin in type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs) [Phase 3]
Phase 3 trial comparing insulin degludec/liraglutide fixed-ratio combination with insulin degludec alone and liraglutide alone in Chinese ad…
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Renoprotective Effects of Dapagliflozin in Type 2 Diabetes [Phase 4]
Phase 4 trial update evaluating renoprotective effects of dapagliflozin in type 2 diabetes; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Usability of Diabetes Dashboard Embedded Within a Patient Web Portal [NA]
A completed clinical trial evaluating the usability of a diabetes dashboard embedded in a patient web portal.
-
CLINICAL_TRIALS trial_result · 2020-07-02Clinical Trial Update: A Single and Multiple-Dose Study of MK-8521 in Healthy and Obese Males (MK-8521-002) [Phase 1]
Phase 1 study evaluating single and multiple doses of MK-8521 in healthy and obese males with Type 2 Diabetes Mellitus completed with result…
-
CLINICAL_TRIALS trial_result · 2020-07-01Clinical Trial Update: 4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes [Phase 1]
A Phase 1 multi-dose, dose-escalation study in patients with Type 2 Diabetes Mellitus has been completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: CARAT: Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 Diabetes [Phase 4]
Phase 4 trial update for canagliflozin vs placebo in post-bariatric patients with persistent type 2 diabetes; study terminated with results …
-
CLINICAL_TRIALS trial_result · 2020-06-25Clinical Trial Update: 16-week Flexible vs. 8-week Semaglutide Titration [Phase 3]
Phase 3 trial update comparing 16-week flexible versus 8-week titration of semaglutide for type 2 diabetes.